Novel point mutation in the splice donor site of exon-intron junction 6 ofthe androgen receptor gene in a patient with partial androgen insensitivity syndrome
I. Sammarco et al., Novel point mutation in the splice donor site of exon-intron junction 6 ofthe androgen receptor gene in a patient with partial androgen insensitivity syndrome, J CLIN END, 85(9), 2000, pp. 3256-3261
Androgen receptor (AR) gene mutations have been shown to cause androgen ins
ensitivity syndrome with altered sexual differentiation in XY individuals,
ranging from a partial insensitivity with male phenotype and azoospermia to
a complete insensitivity with female phenotype and the absence of pubic an
d axillary sexual hair after puberty.
In this study we present an 11-yr-old XY girl, with clinical manifestations
peculiar for impaired androgen biological action, including female phenoty
pe, blind-ending vagina, small degree of posterior labial fusion, and absen
ce of uterus, fallopian tubes, and ovaries. At the time of the diagnosis th
e patient had a FSH/LH ratio according to the puberal stage, undetectable 1
7 beta-estradiol, and high levels of testosterone (80.1 ng/mL). After bilat
eral gonadectomy, performed at the age of 11 yr, histological examination s
howed small embryonic seminiferous tubules containing prevalently Sertoli c
ells and occasional spermatogonia together with abundant fibrous tissue. Mo
lecular study of the patient showed a guanine to thymine transversion in po
sition + 5 of the donor splice site in the junction between exon 6 and intr
on 6 of the AR gene. The result of RT-PCR amplification of the AR messenger
ribonucleic acid from cultured genital skin fibroblasts of the patient sug
gests that splicing is defective, and intron 6 is retained in most of the r
eceptor messenger ribonucleic acid molecules. We show by immunoblotting tha
t most of the expressed protein lacks part of the C-terminal hormone-bindin
g domain, and a small amount of normal receptor is observed. This is probab
ly responsible for the reduced binding capacity in genital skin fibroblasts
of the patient.
The molecular basis of the alteration in this case is a novel, uncommon mut
ation, leading to a phenotype indicative of a partial androgen insensitivit
y syndrome, Quigley's grade 5.